Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6897223rdf:typepubmed:Citationlld:pubmed
pubmed-article:6897223lifeskim:mentionsumls-concept:C0039771lld:lifeskim
pubmed-article:6897223lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:6897223lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:6897223lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:6897223lifeskim:mentionsumls-concept:C0439801lld:lifeskim
pubmed-article:6897223lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:6897223lifeskim:mentionsumls-concept:C0870078lld:lifeskim
pubmed-article:6897223pubmed:issue10lld:pubmed
pubmed-article:6897223pubmed:dateCreated1983-1-7lld:pubmed
pubmed-article:6897223pubmed:abstractTextIntravenous aminophylline was administered to 13 subjects (6 normal, 7 with chronic obstructive pulmonary disease), and multiple blood specimens were drawn over an 8-hour period for theophylline analysis. Half of the samples were obtained during the distribution phase of the drug and the remainder during the elimination phase. These data were entered into a computer program that both calculates and graphically displays individual two-compartment pharmacokinetic data, and recommends a dosing regimen. Analysis of these data demonstrates wide variability in the theophylline volume of distribution, half-life, and predicted dosage regimen. Dosage regimens can be individualized by obtaining two specimens for theophylline analysis during the elimination phase after intravenous administration of the drug; these regimens correlate extremely well (r2 = 0.95) with those designed using all the data points.lld:pubmed
pubmed-article:6897223pubmed:languageenglld:pubmed
pubmed-article:6897223pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6897223pubmed:citationSubsetIMlld:pubmed
pubmed-article:6897223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6897223pubmed:statusMEDLINElld:pubmed
pubmed-article:6897223pubmed:monthOctlld:pubmed
pubmed-article:6897223pubmed:issn0012-6578lld:pubmed
pubmed-article:6897223pubmed:authorpubmed-author:RobinsonJ DJDlld:pubmed
pubmed-article:6897223pubmed:authorpubmed-author:BoysenP GPGlld:pubmed
pubmed-article:6897223pubmed:authorpubmed-author:ArietMMlld:pubmed
pubmed-article:6897223pubmed:authorpubmed-author:KrischerJ PJPlld:pubmed
pubmed-article:6897223pubmed:authorpubmed-author:LupkiewiczS...lld:pubmed
pubmed-article:6897223pubmed:issnTypePrintlld:pubmed
pubmed-article:6897223pubmed:volume16lld:pubmed
pubmed-article:6897223pubmed:ownerNLMlld:pubmed
pubmed-article:6897223pubmed:authorsCompleteYlld:pubmed
pubmed-article:6897223pubmed:pagination752-8lld:pubmed
pubmed-article:6897223pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6897223pubmed:meshHeadingpubmed-meshheading:6897223-...lld:pubmed
pubmed-article:6897223pubmed:meshHeadingpubmed-meshheading:6897223-...lld:pubmed
pubmed-article:6897223pubmed:meshHeadingpubmed-meshheading:6897223-...lld:pubmed
pubmed-article:6897223pubmed:meshHeadingpubmed-meshheading:6897223-...lld:pubmed
pubmed-article:6897223pubmed:meshHeadingpubmed-meshheading:6897223-...lld:pubmed
pubmed-article:6897223pubmed:meshHeadingpubmed-meshheading:6897223-...lld:pubmed
pubmed-article:6897223pubmed:meshHeadingpubmed-meshheading:6897223-...lld:pubmed
pubmed-article:6897223pubmed:year1982lld:pubmed
pubmed-article:6897223pubmed:articleTitlePrediction of theophylline dosage regimens from limited serum sampling.lld:pubmed
pubmed-article:6897223pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6897223pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6897223lld:pubmed